**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 143-16-8 |Dihexylamine | >99 | 205-588-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 23/24 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation and in contact with skin. Danger of cumulative
effects.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal
damage.
Skin:
May be fatal if absorbed through the skin. Causes skin burns. May
cause skin rash (in milder cases), and cold and clammy skin with
cyanosis or pale color.
Ingestion:
Harmful if swallowed. May cause severe and permanent damage to the
digestive tract. Causes gastrointestinal tract burns. May cause
perforation of the digestive tract. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. Aspiration may lead
to pulmonary edema. May cause systemic effects.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid immediately. Do NOT allow victim to rub eyes or keep
eyes closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Cool containers with
flooding quantities of water until well after fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid ingestion and inhalation. Use with
adequate ventilation. Discard contaminated shoes.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Corrosives area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 143-16-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: amine-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 113 deg C @ 10.00mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 94 deg C ( 201.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .8000g/cm3
Molecular Formula: C12H27N
Molecular Weight: 185.35
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Acid anhydrides, acid chlorides, strong acids, strong oxidizing
agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 143-16-8: IH6600000
LD50/LC50:
CAS# 143-16-8: Draize test, rabbit, eye: 750 ug/24H Severe; Oral,
rat: LD50 = 380 mg/kg; Skin, rabbit: LD50 = 170 mg/kg.
Carcinogenicity:
Dihexylamine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, CORROSIVE, ORGANIC, N.O.S.*
Hazard Class: 6.1 (8)
UN Number: 2927
Packing Group: II
IMO
Shipping Name: TOXIC LIQUID, CORROSIVE, ORGANIC, N.O.S.
Hazard Class: 6.1 (8)
UN Number: 2927
Packing Group: II
RID/ADR
Shipping Name: TOXIC LIQUID, CORROSIVE, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2927
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24 Toxic by inhalation and in contact with
skin.
R 33 Danger of cumulative effects.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 143-16-8: 2
Canada
CAS# 143-16-8 is listed on Canada's NDSL List.
CAS# 143-16-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 143-16-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/29/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Piperonal, 99%
| 120-57-0 |
|
5-Chlorouracil, 99%
| 1820-81-1 |
|
Benzáa??anthracene-7,12-dione, 97% (uv-vis)
| 2498-66-0 |
|
(3,4-Dimethoxyphenyl)acetic acid, 99%
| 93-40-3 |
|
1-Naphthaleneacetamide, 98%
| 86-86-2 |
|
Chlorosulfonyl isocyanate, 98+%
| 1189-71-5 |
|
4-Chloro-4'-Fluorobutyrophenone, 97+% (GC)
| 3874-54-2 |
|
Vitamin d2 (calciferol),99% (hplc)
| 50-14-6 |
|
Diethyl Phosphonoacetaldehyde Diethyl Acetal, Tech. 90%
| 7598-61-0 |
|
3,5-Dimethoxyacetophenone, 97%
| 39151-19-4 |
|
Palladium on Activated Carbon (5% Pd)
| |
|
Cyclododecene, Tech., Predominantly Trans
| 1501-82-2 |
|
4-Hydroxy-6-methyl-2-pyrone
| 675-10-5 |
|
Benzoyl bromide, 97%
| 618-32-6 |
|
Prostaglandin e1, 98+%
| 745-65-3 |
|
4,4'-Dimethylbenzil, 99+%
| 3457-48-5 |
|
Chrysoidin
| 532-82-1 |
|
d-Limonene
| 5989-27-5 |
|
Mitomycin C (Contains 2mg Mitomycin C and 48mg Sodium Chloride)
| 50-07-7 |
|
Butyl methacrylate/isobutyl methacrylate copolymer, high molecular
| 9011-53-4 |
|
Bis-(2-Methylallyl)Cycloocta-1,5-Diene Ruthenium(II) Complex
| 0-00-1 |
|
d-Lysergic acid hydrate, 95% *** controled product kb 11.6.87 ***
| 82-58-6 |
|
2-Bromo-1-Indanol, 99%
| 5400-80-6 |
|
Ruthenium(IV) oxide hydrate
| 32740-79-7 |
|
2-Chlorocyclohexanol, Tech., 90%
| 1561-86-0 |
|
5-Amino-2,2,4-Trimethyl-1-Cyclopentane-Methylamine, 99%, Mixture of
| 67907-32-8 |
|
2,3,4-Trimethoxybenzoic acid, 98+%
| 573-11-5 |
|
1,3-Dibromo-5,5-dimethylhydantoin, 98%
| 77-48-5 |
|
Dicumarol, 99%
| 66-76-2 |
|
Tetraphenylphosphonium Chloride 99%
| 2001-45-8 |
|
Benzo[k]fluoranthene, 99+% (tlc)
| 207-08-9 |
|
Dihexylamine, 99+% (GC)
| 143-16-8 |
|
Propargyl Alcohol, 99%
| 107-19-7 |
|
Borane-tert-butylamine complex, powder
| 7337-45-3 |
|
Tri-n-butyltin methoxide, 97%
| 1067-52-3 |
|
5-Methoxyindole-3-Carboxaldehyde, 99+%
| 10601-19-1 |
|
2,4-Dichlorophenoxyacetic acid
| 94-75-7 |
|
4-Phenylpyridine, 99%
| 939-23-1 |
|
2-Naphthalenesulfonic acid hydrate, 99%
| 120-18-3 |
|
Benzanthrone, 99%
| 82-05-3 |
|
Tripentylamine, 99%
| 621-77-2 |
|
BOC-D-Arginine Hydrochloride, Hydrate, 99%
| 114622-81-0 |
|
Phenylphosphonothioic dichloride, 97%
| 3497-00-5 |
|
3,3,5,5-Tetramethylpyrroline-N-Oxide, 98%
| 10135-38-3 |
|
1-(2-Aminoethyl)-2-Methyl-5-Nitroimidazole Dihydrochloride
| 49575-10-2 |
|
Bis(2-ethylhexyl) adipate
| 103-23-1 |
|
M-Tolyl Acetate
| 122-46-3 |
|
1,4-Dioxa-8-azaspiro(4.5)decane, 98%
| 177-11-7 |
|
DL-Homocysteinethiolactone Hydrochloride, 99%
| 6038-19-3 |
|
Ethyl Benzoate, 99+%
| 93-89-0 |
|
|